Effect of asoprisnil on the pharmacokinetics of triazolam and its metabolite in healthy female subjects.

被引：0
|
作者：
Lee, RD [1 ]
Mulford, D [1 ]
Witt, G [1 ]
Chwalisz, K [1 ]
机构：
[1] TAP Pharmaceut Prod Inc, Lake Forest, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.285
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P79 / P79
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics of Tapentadol in Healthy Elderly and Young Subjects.
    Smit, J. W.
    Haeufel, T.
    Ravenstijn, P.
    Brett, M.
    Kleideiter, E.
    Mangold, B.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1079 - 1079
  • [22] THE EFFECT OF EVEROLIMUS (EVE) ON THE PHARMACOKINETICS (PK) OF MIDAZOLAM (MID) IN HEALTHY SUBJECTS.
    Urva, S.
    Bouillaud, E.
    Delaney, R.
    Jappe, A.
    Cheung, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S128 - S128
  • [23] Effect of gastric pH on plasma concentrations of tegaserod (HTF 919) and its major metabolite in healthy subjects.
    Zhou, HH
    Khalilieh, S
    Campestrini, J
    Appel-Dingemanse, S
    Lachman, L
    McLeod, JF
    GASTROENTEROLOGY, 2000, 118 (04) : A1206 - A1207
  • [24] Effect of asoprisnil, a novel selective progesterone receptor modulator, on the QT interval in healthy female subjects
    Lee, RD
    Edmonds, A
    Chwalisz, K
    Vernillet, L
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1083 - 1083
  • [25] PHARMACOKINETICS OF ZIDOVUDINE AND ITS METABOLITE IN HEALTHY-SUBJECTS AND IN UREMIC PATIENTS
    PIOGER, JC
    TABURET, AM
    COLIN, JN
    COLANERI, S
    FILLASTRE, JP
    SINGLAS, E
    THERAPIE, 1989, 44 (06): : 401 - 404
  • [26] Pharmacokinetics of loratadine and its active metabolite descarboethoxyloratadine in healthy Chinese subjects
    Zhang, YF
    Chen, XY
    Zhong, DF
    Dong, YM
    ACTA PHARMACOLOGICA SINICA, 2003, 24 (07) : 715 - 718
  • [27] PHARMACOKINETICS OF VORAPAXAR AND ITS METABOLITE SCH 2046273 (M20) FOLLOWING ORAL ADMINISTRATION IN HEALTHY CHINESE AND US SUBJECTS.
    Statkevich, P.
    Kosoglou, T.
    Kumar, B.
    Li, J.
    Xuan, F.
    Wang, Z.
    Meehan, A. G.
    Cutler, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S54 - S54
  • [28] Effect of food on the pharmacokinetics of delayed-release valproate in healthy human subjects.
    Nangia, A
    Cullen, E
    Niecestro, R
    Friedhoff, L
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (09): : 1032 - 1032
  • [29] Pharmacokinetics (PK) and pharmacodynamics (PD) of lanoteplase in healthy subjects.
    Vachharajani, N
    Shyu, W
    Stouffer, B
    Raymond, R
    Liao, W
    Tay, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 180 - 180
  • [30] Population pharmacokinetics of cefixime in Chinese male healthy subjects.
    Cui, Y
    Zhou, Y
    Sun, P
    Zhao, X
    Liu, Y
    Sun, Z
    Lu, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P24 - P24
12345